Hodgkin Lymphoma Treatment: State-Of-The-Art

The last decade has seen exciting developments in the field of Hodgkin lymphoma therapy. Several large randomized trials have confirmed the benefit of a PET response-adapted strategy for the treatment of newly diagnosed Hodgkin lymphoma, and three drugs have received FDA approval for the treatment of relapsed/refractory disease.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research